Literature DB >> 32519136

Treat all COVID 19-positive patients, but do not forget those negative with chronic diseases.

Viganò Mauro1, Mantovani Lorenzo2,3, Cozzolino Paolo3, Harari Sergio4.   

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) has distressed our working practice. Infectious disease specialists, pneumologists and intensivists were not enough to face the enormous amount of patients that needed hospital care; therefore, many doctors have been recruited from other medical specialties trying to take care of as many patients as possible. The 'call to duty' of such doctors for urgent COVID-19 cases, however, diverted the attention from the care of patients with chronic conditions, which might have been neglected or undervalued. In this extremely difficult time, the standard of care of chronic patients has been reduced and this might have determined an increased rate of complications secondary to undermanagement. Thousands of patients with acute and chronic non-COVID-19 conditions have not accessed specialist care in the last weeks in Italy. Moreover, even those patients who have had scheduled an outpatient visit did not attend it for fear of leaving their home or due to the inability to go. During the pandemic, there was a drastic reduction in the number of hospital admissions for any medical conditions different from COVID-19. Self-presentation to the emergency department (ED) has been discouraged and the patients' own fear of being infected by going to the hospital led to also a significant decrease in ED access. During the lockdown, in San Giuseppe Hospital MultiMedica IRCCS, Milan, the ED admissions dropped from the mean of 2361/month in December 2019-February 2020 to 1102 (- 53%) and 861 (- 63%) in March and April 2020, respectively. For all the above-mentioned reasons, it is possible that some clinical conditions will further progress with a significant increase in morbidity and mortality. To prevent this, it is essential that patients with chronic conditions should be at least monitored and managed with telephone or online health consultation, identifying those who need urgent access to care, prioritizing outpatient visits based on disease severity. Patients with mild conditions could be managed outside the hospital by implementing telemedicine and creating networks of general practitioners who can consult with in-hospital specialists.

Entities:  

Keywords:  COVID-19; Chronic disease; Emergency department; SARS-CoV-2

Mesh:

Year:  2020        PMID: 32519136      PMCID: PMC7282471          DOI: 10.1007/s11739-020-02395-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


Newly identified SARS CoV-2 may cause mild and self-limiting illness with upper respiratory tract symptoms, non-life-threatening pneumonia and severe pneumonia with acute respiratory distress syndrome (ARDS) that begin with mild symptoms and then progress rapidly to respiratory failure requiring intensive care management [1-3]. This latter occurrence affects above all older people or those with co-morbidities, i.e., diabetes, arterial hypertension, pulmonary disease, and other chronic conditions [1]. The current outbreak of coronavirus disease 2019 (COVID-19) has been classified by the World Health Organization as a global pandemic. Up to April 24, 2020 in Italy, the most affected European country, there had been 192.994 confirmed SARS-CoV-2 infections and 25.969 deaths [4]. The COVID-19 pandemic has distressed our working practice, as health-care providers, as the number of infected patients grew in our hospitals. Infectious disease specialists, pneumologists and intensivists were not enough to face the enormous amount of patients that needed hospital care, therefore many doctors have been recruited from other medical specialities, often completely different, trying to take care of as many patients as possible. Endocrinologists, cardiologists, gastroenterologists, haematologists had to refresh their knowledge on interpreting arterial blood gas analysis, managing non-invasive ventilators and prescribing antiretroviral drugs in respiratory care units (ICU). The ‘call to duty’ of doctors for urgent COVID-19 cases, however, diverted the attention from the care of patients with chronic condition which might have been neglected or undervalued. In this extremely difficult time, the standard of care of chronic patients has been reduced and this might have determined an increased rate of complications secondary to undermanagement. Thousands of patients with acute and chronic non-COVID-19 conditions have not accessed specialist care in the last weeks in Italy. Moreover, even those patients who have had scheduled an outpatient visit did not attend it for fear of leaving their home, the inability to go, due to problems of public transport, or the lack of someone who can bring them to the clinic. Self-presentation to the emergency department (ED) has been discouraged and the patients' own fear of being infected by going to hospital led to a further reduction in ED access [5]. By analysing the ED admissions during the COVID-19 lockdown in San Giuseppe Hospital MultiMedica IRCCS, Milan, we compare the data from March/April 2020 to December 2019–February 2020 (Table 1). The number of patients admitted to the ED dropped from the mean of 2361 patients/month to 1102 (− 53%) and 861 (− 63%) in March and April 2020, respectively. The ED admissions by medical specialities showed a significant drop in traumatology, dermatology, gastroenterology/hepatology and cardiology, with an increase of accesses for respiratory diseases (from a mean of 12% in previous months to 36% and 29% in March and April 2020, respectively), with a significant increase in some presentation symptoms at triage such as fever, cough and dyspnoea that increased from a mean of 3%/month to 6%, 6% and 12%, respectively. At the same time, red codes at triage admission doubled (3.9% in March and 2.7% in April 2020) compared to the 1.5% of the prior 3 months, with a concomitant significant reduction of white codes.
Table 1.

Variations in the emergency department (ED) admittances from March/April 2020 compared to December 2019–February 2020

December 2019January 2020February 2020March 2020April 2020
ED access, no. (%)
 Cardiology88 (4)100 (4)97 (4.2)28 (2.6)22 (2.6)
 Dermatology114 (5)148 (6)150 (6.4)36 (3.3)5 (0.6)
 Gastroenterology/hepatology298 (13)300 (12)314 (13.5)124 (11.2)81 (9.4)
 Gynaecology/obstetrics306 (13.5)293 (11.8)261 (11)128 (11.6)151 (17.5)
 Musculoskeletal325 (14.4)256 (10.3)114 (5)24 (2.2)23 (2.7)
 Neurology283 (12)215 (8.7)227 (9.8)98 (8.9)71 (8.2)
 Other308 (13.5)461 (18.5)553 (24)184 (16.7)197 (22.9)
 Respiratory196 (8.6)297 (12)321 (14)397 (36)249 (29)
 Traumatology264 (12)325 (13)190 (8.1)33 (3)22 (2.5)
 Urology97 (4)91 (3.7)91 (4)50 (4.5)40 (4.6)
 Total2279248623181102861
Symptoms at triage, no. (%)*
 Fever48 (2.1)86 (3.4)105 (4.5)115 (10.4)92 (10.6)
 Cough60 (2.6)89 (3.6)78 (3.3)107 (9.7)18 (2)
 Dyspnoea98 (4.3)52 (2)138 (6)118 (10.7)110 (12.8)
 Chest pain66 (2.9)67 (2.7)67 (2.9)18 (1,6)12 (1,4)
Severity code at triage, no. (%)
 Red31 (1.4)38 (1.5)36 (1.6)43 (3.9)23 (2.7)
 Yellow359 (15.7)412 (17)365 (15.7)250 (22.7)129 (15)
 Green1245 (54.6)1431 (57.5)1174 (50.7)666 (60.4)542 (63)
 White644 (28.3)605 (24)743 (32)143 (13)167 (19.3)
Men, no. (%)948 (41.6)1019 (41)987 (42.6)513 (46.5)328 (38)
Median age, years5253515857
Death in ED, no. (%)7 (0.3)12 (0.5)16 (0.7)48 (4.3%)28 (3.2)
Hospitalization rate, no. (%)294 (13)302 (12.1)305 (13.1)290 (26.3)241 (28)

*As the predominant presentation symptom

Variations in the emergency department (ED) admittances from March/April 2020 compared to December 2019–February 2020 *As the predominant presentation symptom All these data are justified by the increased number of patients with pneumonia and ARDS who were admitted to ED, which also explains the increased hospitalization rate as well as the rate of patients who died in ED (from a mean of 13%/month to 26% and 28%, and from a mean of 0.5%/month to 4.3% and 3.2% in March and April 2020, respectively) due to the greater severity of disease such in patients. Another aspect that may have had a negative impact on patient’s health could be linked to a reduced drug intake. Anxiety about the period we are experiencing and the impossibility of getting regular medical care and prescriptions for adequate supplies may have caused a reduced adherence to treatment [6]. Furthermore, the monitoring of some life-saving drugs such as oral anticoagulants, immunosuppressants or anticomitial may have been reduced. For all these reasons, it is possible that some clinical conditions progressed until they became a real urgency. A recent study showed that the mortality from acute heart attack in Italy has almost tripled for late clinical presentation caused by patients avoiding hospitals for fear of SARS-CoV-2 infection [7], a phenomenon that is being observed also in other European countries [8] and in the USA [9]. To prevent this in the near future, patients with chronic conditions should be at least monitored and managed with telephone or online health consultation, identifying those who need urgent access to care. Prioritizing outpatient visits based on disease severity in patients with chronic diseases already in regular follow-up could be done through semi-automated artificial intelligence systems to avoid further worsening of the underlying diseases. Patients with mild conditions could on the other hand be managed outside the hospital by implementing telemedicine and creating networks of general practitioners who can consult with in-hospital specialists. Based on our own experience, we believe that to enable this, it is of key importance identifying dedicated medical personnel (physician and nurses) who can take care of these patients’ selection. Telemedicine services eliminate the need to address patients to overpopulated hospitals and provide near real-time consultation. To do this, we must not rely only on individual willing, but plan with the health policymakers the best management strategies, also endowing this with a medico-legal value. For all hospital-dispensing drugs, it is necessary to guarantee a timely supply, sending recipe codes or directly the drugs to the patient's home, avoiding unnecessary access to the hospital and, as much as possible, stressing the importance of compliance to treatment, which could decrease the generalized anxiety [6]. There is an urgent need to manage all patients with emergencies as well as the most fragile ones who need urgent access to care, with appropriate standards of care and dedicated preventive measures and protocols against the risk of SARS-CoV-2 infection. We must reduce as much as possible and as soon as possible the risk of acquiring in-hospital infection, especially considering that asymptomatic cases may be a vector of the virus and can infect medical and nursing staffs. The goal is to guarantee the best and safest treatment to all patients who will return to hospitals to be treated according to the recommendations and the published guidelines [10-12]. We believe that all patients hospitalized urgently should have a swab and a chest X-ray as soon as they enter the ED and have the result before admission to the ward, while those considered for elective procedures should have the swab performed the day before admission. In case of a negative swab and chest X-ray result and in the absence of suspicious symptoms of virus infection, the patients can be admitted to the ordinary ward, where only SARS-CoV-2-negative patients are hospitalized, whereas in case of a positive evaluation the patients should be placed in the ward dedicated only to SARS-CoV-2-positive patients, with separate staff of nurses and physician. If we will be able to do all this in the next few weeks, we will respond to their medical needs, avoiding an excessive increase in morbidity and mortality.
  10 in total

Review 1.  Respiratory Protection Considerations for Healthcare Workers During the COVID-19 Pandemic.

Authors:  Christopher R Friese; Tener Goodwin Veenema; James S Johnson; Sundaresan Jayaraman; James C Chang; Linda Hawes Clever
Journal:  Health Secur       Date:  2020-04-22

2.  Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.

Authors:  Giacomo Grasselli; Antonio Pesenti; Maurizio Cecconi
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

3.  Letter to the Editor: Clinical Management of Nonrespiratory Diseases in the COVID-19 Pandemic: What Have We Done and What Needs to Be Done?

Authors:  Mauro Viganò; Antonio Voza; Sergio Harari; Alessandro Eusebio; Marta Ripoll Pons; Marco Bordonali; Vittorio Preti; Maria Grazia Rumi; Salvatore Badalamenti; Alessio Aghemo
Journal:  Telemed J E Health       Date:  2020-05-19       Impact factor: 3.536

4.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

5.  Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.

Authors:  Jos H Verbeek; Blair Rajamaki; Sharea Ijaz; Riitta Sauni; Elaine Toomey; Bronagh Blackwood; Christina Tikka; Jani H Ruotsalainen; F Selcen Kilinc Balci
Journal:  Cochrane Database Syst Rev       Date:  2020-04-15

6.  Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic.

Authors:  Santiago Garcia; Mazen S Albaghdadi; Perwaiz M Meraj; Christian Schmidt; Ross Garberich; Farouc A Jaffer; Simon Dixon; Jeffrey J Rade; Mark Tannenbaum; Jenny Chambers; Paul P Huang; Timothy D Henry
Journal:  J Am Coll Cardiol       Date:  2020-04-10       Impact factor: 24.094

7.  Early consensus management for non-ICU acute respiratory failure SARS-CoV-2 emergency in Italy: from ward to trenches.

Authors:  Michele Vitacca; Stefano Nava; Pierachille Santus; Sergio Harari
Journal:  Eur Respir J       Date:  2020-05-21       Impact factor: 16.671

8.  An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience Under Real-World Suboptimal Conditions.

Authors:  Nicola Cosentino; Emilio Assanelli; Luca Merlino; Mario Mazza; Antonio L Bartorelli; Giancarlo Marenzi
Journal:  Can J Cardiol       Date:  2020-04-17       Impact factor: 5.223

Review 9.  The psychological impact of quarantine and how to reduce it: rapid review of the evidence.

Authors:  Samantha K Brooks; Rebecca K Webster; Louise E Smith; Lisa Woodland; Simon Wessely; Neil Greenberg; Gideon James Rubin
Journal:  Lancet       Date:  2020-02-26       Impact factor: 79.321

Review 10.  Perioperative COVID-19 Defense: An Evidence-Based Approach for Optimization of Infection Control and Operating Room Management.

Authors:  Franklin Dexter; Michelle C Parra; Jeremiah R Brown; Randy W Loftus
Journal:  Anesth Analg       Date:  2020-07       Impact factor: 6.627

  10 in total
  25 in total

Review 1.  The Impact of the SARS-CoV-2 Pandemic on Healthcare Provision in Italy to non-COVID Patients: a Systematic Review.

Authors:  Gianmarco Lugli; Matteo Maria Ottaviani; Annarita Botta; Guido Ascione; Alessandro Bruschi; Federico Cagnazzo; Lorenzo Zammarchi; Paola Romagnani; Tommaso Portaluri
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

2.  Effects of SARS-CoV-2 pandemic on follow-up and pharmacological treatment of chronic diseases in undocumented migrants.

Authors:  Gianfrancesco Fiorini; Matteo Franchi; Giovanni Corrao; Roberta Tritto; Sara Fadelli; Antonello Emilio Rigamonti; Alessandro Sartorio; Silvano Gabriele Cella
Journal:  BMJ Nutr Prev Health       Date:  2021-07-02

3.  Changes of Acute Kidney Injury Epidemiology during the COVID-19 Pandemic: A Retrospective Cohort Study.

Authors:  Pasquale Esposito; Elisa Russo; Daniela Picciotto; Francesca Cappadona; Yuri Battaglia; Giovanni Battista Traverso; Francesca Viazzi
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

4.  Request of hospital care dropped for TIA but remained stable for stroke during COVID-19 pandemic at a large Italian university hospital.

Authors:  Maurizio Balestrino; Alberto Coccia; Alessandra Silvia Boffa; Andrea Furgani; Francesco Bermano; Cinzia Finocchi; Monica Laura Bandettini di Poggio; Laura Malfatto; Daniele Farinini; Angelo Schenone
Journal:  Intern Emerg Med       Date:  2020-10-15       Impact factor: 3.397

5.  Contactless: a new personalised telehealth model in chronic pediatric diseases and disability during the COVID-19 era.

Authors:  Eugenio Mercuri; Giuseppe Zampino; Alisha Morsella; Marika Pane; Roberta Onesimo; Carmen Angioletti; Piero Valentini; Claudia Rendeli; Antonio Ruggiero; Lorenzo Nanni; Antonio Chiaretti; Giovanni Vento; David Korn; Emilio Meneschincheri; Paolo Sergi; Giovanni Scambia; Walter Ricciardi; Andrea Cambieri; Antonio Giulio De Belvis
Journal:  Ital J Pediatr       Date:  2021-02-12       Impact factor: 2.638

6.  Access to Healthcare during COVID-19.

Authors:  Alicia Núñez; S D Sreeganga; Arkalgud Ramaprasad
Journal:  Int J Environ Res Public Health       Date:  2021-03-14       Impact factor: 3.390

7.  Don't stop walking: the in-home rehabilitation program for peripheral artery disease patients during the COVID-19 pandemic.

Authors:  Nicola Lamberti; Sofia Straudi; Roberto Manfredini; Alfredo De Giorgi; Vincenzo Gasbarro; Paolo Zamboni; Fabio Manfredini
Journal:  Intern Emerg Med       Date:  2021-01-07       Impact factor: 3.397

8.  The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study.

Authors:  Ingmar Schäfer; Heike Hansen; Agata Menzel; Marion Eisele; Daniel Tajdar; Dagmar Lühmann; Martin Scherer
Journal:  BMC Fam Pract       Date:  2021-06-23       Impact factor: 2.497

9.  Threat of COVID-19 impacting on a quaternary healthcare service: a retrospective cohort study of administrative data.

Authors:  Elissa McNamara; Leanne Saxon; Katherine Bond; Bruce Cv Campbell; Jo Douglass; Martin J Dutch; Leeanne Grigg; Douglas Johnson; Jonathan C Knott; Digsu N Koye; Mark Putland; David J Read; Benjamin Smith; Benjamin Nj Thomson; Deborah A Williamson; Steven Yc Tong; Timothy N Fazio
Journal:  BMJ Open       Date:  2021-06-24       Impact factor: 2.692

10.  "COVID-19: diagnosis, management and prognosis": a new topical collection of Internal and Emergency Medicine.

Authors:  Riccardo Polosa; Michele Spinicci; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2020-07-30       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.